News
The Bastide Group enters the respiratory care devices market in Italy
Caissargues, July 18, 2022
The Bastide Group announces the acquisition of a majority stake in Oxystore, a company based near Milan, Italy. Oxystore specializes in home diagnosis and online sales of
BASTIDE : Acceleration in growth in the third quarter, to 6% - Outlook confirmed
Caissargues, May 12, 2022
In €k 2020-2021 2021-2022 Change 3rd quarter revenue 111,669 118,446 +6.1% 9-month revenue 333,033 341,491 +2.5%
Group
MEDICREA Reports Third Quarter 2020 Sales
The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market –MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling
MEDICREA Reports First Half 2020 Results
The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market –MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling
MEDICREA Announces the Appointment of an Independent Expert
The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market –MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling
Medtronic to Acquire Medicrea
Medtronic plc (NYSE:MDT), a global leader in medical technology, and Medicrea (Euronext Growth Paris: FR0004178572 – ALMED Medicrea; OTCQX Best Market – MRNTF), a pioneer in the transformation of
MEDICREA Reports First Half 2020 Sales
The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market –MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling
MEDICREA Reports 2020 First Quarter Results
The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market –MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling
MEDICREA Reports 2019 Annual Results and 2020 First Quarter Sales
The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market –MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling
MEDICREA Is Protected From the Consequences of the COVID-19 Pandemic
The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market –MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling
MEDICREA® Announces FDA Clearance of the World’s First Patient-Matched Spinal Interbody Cages
MEDICREA® (Euronext Growth Paris : FR0004178572 – ALMED, PEA-PME eligible and OTCQX : MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling
MEDICREA®’s UNiD® ASI Technology Hits 5,000th Patient-Specific Spine Surgery Milestone With Strong Penetration of the Degenerative and Minimally Invasive Market Segment
MEDICREA® (Euronext Growth Paris : FR0004178572 – ALMED, PEA-PME eligible and OTCQX : MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling
MEDICREA® Reports 2019 Annual Sales
The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market – MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling
MEDICREA Announces Preliminary Discussions With U.S. Strategic Partners
The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market – MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling
MEDICREA® Secures 7 New US Patents Around Its Proprietary Platform Technology UNiD™ ASI And Reinforces Barriers to Entry for Competitors
The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX
Best Market –MRNTF), pioneering the transformation of spinal surgery
through Artificial Intelligence,
Medicrea Reports Third Quarter 2019 Financial Results
The Medicrea Group (Euronext Growth Paris: FR0004178572-ALMED ; OTCQX Best Market –MRNTF), pioneering the digital transformation of spinal surgery through artificial Intelligence, predictive
Medicrea forme une joint-venture en Belgique avec un distributeur stratégique
BASTIDE : Avis de réunion Assemblée générale extraordinaire du 03 mai 2018
MEDICREA : RACHAT ACTIONS - CONTRAT DE LIQUIDITE -FEVRIER 2018
MEDICREA : Declaration_des_droits_de_vote_AMF_28-02-2018
BASTIDE : Mise à disposition du rapport financier semestriel 2017-2018
BASTIDE : Résultats semestriels 2017-2018 : Chiffre d'affaires : +26% : Résultat opérationnel courant : +28%
MEDICREA participera à la Canaccord Genuity Musculoskeletal Conference et présentera des résultats cliniques à l'AAOS 2018 aux Etats-Unis
BASTIDE : Nombre d'actions et de droits de vote au 28 février 2018
MEDICREA : Declaration_des_droits_de_vote_AMF_31-01-2018